SARS-CoV-2

Hsiang-Chi Huang1, Davide Angeletti2

  • 1Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden; Wallenberg Center for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.

Trends in immunology
|October 7, 2023
PubMed
概括

新的强效人类单克隆抗体 (mAbs) 中和了所有SARS-CoV-2变种. 这些抗体将尖端蛋白受体结合域 (RBD) 锁定在向下位置,阻止病毒的进入.